Transdermal administration of oxybutynin
    3.
    发明授权
    Transdermal administration of oxybutynin 失效
    透皮给药奥昔布宁

    公开(公告)号:US5411740A

    公开(公告)日:1995-05-02

    申请号:US193661

    申请日:1994-02-08

    摘要: The present invention is directed to the transdermal administration of oxybutynin together with a suitable permeation enhancer. The invention includes a transdermal drug delivery device comprising a matrix adapted to be placed in oxybutynin- and permeation enhancer-transmitting relation with the skin site. The matrix contains sufficient amounts of a permeation enhancer and of oxybutynin, in combination, to continuously administer to the skin for a predetermined period of time the oxybutynin to provide an effective therapeutic result. The invention is also directed to a method for the transdermal administration of a therapeutically effective amount of oxybutynin together with a skin permeation-enhancing amount of a suitable permeation enhancer.

    摘要翻译: 本发明涉及奥昔布宁与合适的渗透增强剂的透皮给药。 本发明包括透皮药物递送装置,其包含适于与皮肤部位置于奥昔布宁和渗透增强剂 - 传递关系中的基质。 基质含有足量的渗透促进剂和奥昔布宁组合,以持续给予皮肤预定的时间,奥昔布宁提供有效的治疗结果。 本发明还涉及用于透皮给药治疗有效量的奥昔布宁以及皮肤渗透增强剂量的合适的渗透增强剂的方法。

    Transdermal contraceptive formulations methods and devices
    5.
    发明授权
    Transdermal contraceptive formulations methods and devices 失效
    透皮避孕配方法及装置

    公开(公告)号:US5512292A

    公开(公告)日:1996-04-30

    申请号:US361356

    申请日:1994-12-21

    摘要: The present invention provides compositions and methods for the transdermal administration of a contraceptively effective amount of gestodene and estrogen, such as ethinyl estradiol, in combination, together with a suitable permeation enhancer. The amount of the estrogen codelivered is kept at an about constant and contraceptively effective rate while the amount of gestogen codelivered varies depending on the phase of the menstrual cycle but remains at a contraceptively effective rate. The size of the system may also vary depending on the amount of gestogeno be delivered.

    摘要翻译: 本发明提供组合物和合适的透皮给药避孕有效量的孕二烯酮和雌激素(例如乙炔雌二醇)的组合物和方法以及合适的渗透增强剂。 雌激素编码的数量保持在大约恒定和避孕有效率,而代谢产物的数量根据月经周期的相位而变化,但仍然是避孕有效率。 系统的尺寸也可以根据递送的gestogeno的量而变化。